As most of the U.S. shifts to daylight saving time this week, a new study reveals that malpractice severity and payment decisions are higher in this part of the year than during standard time.
The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.